Physician profile
Austin Mueller
NPI 1245963008
$1,432.52
in general payments reported to CMS, 2019-2025
13 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $332 · 2024: $535 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $284.92 | 2023-2024 | Infinity, Infinity Adaptis, Ortholoc 2 Lapifuse |
| Kerecis Limited | $283.06 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $158.32 | 2025 | |
| Integra Lifesciences Corporation | $152.39 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Linvatec Corporation | $128.18 | 2025 | Biobrace 23mm, Neospan, Ibs |
| Orthofix Medical, INC. | $125.26 | 2024-2025 | Physio-Stim, Accelstim |
| Bone Support INC. | $112.17 | 2024 | Cerament G, Ceramentbone Void Filler |
| Medline Industries LP | $63.33 | 2023 | |
| Smith+Nephew, INC. | $40.00 | 2024-2025 | Stravix, Grafix, Oasis |
| Merck Sharp & Dohme LLC | $23.70 | 2024 | Bridion |
| Surgenex LLC | $22.83 | 2025 | Surmatrix, Renograft, Ardeograft |
| Zimvie INC. | $20.98 | 2023 | |
| Enduromed, LLC | $17.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.